...
search icon
blte-img

Belite Bio Inc ADR Share Price

BLTE
NAQ
$173.441
-$2.4
(-1.36%)
1D
Industry: Biotechnology Sector: Health Care

Belite Bio Inc ADR Analyst Forecast

Belite Bio Inc ADR Share Price Chart

Belite Bio Inc ADR Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.60B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
55.93K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-1.46
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$49 L
$200 H
$173.441

About Belite Bio Inc ADR, Common Stock

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an anti-retinol-binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd. more

Industry: BiotechnologySector: Health Care

Belite Bio Inc ADR Stock Returns

Time FrameBLTESectorS&P500
1-Week Return-0.6%1.31%-1.33%
1-Month Return9.89%1.27%0.78%
3-Month Return50.41%3.74%2.61%
6-Month Return170.73%15.81%6.19%
1-Year Return213.66%8.89%11.68%
3-Year Return457.16%19.23%67.81%
5-Year Return1560.43%35.04%74.06%

Belite Bio Inc ADR Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue17.00K30.00K198.00K399.00K449.00K[{"date":"2020-12-31","value":3.79,"profit":true},{"date":"2021-12-31","value":6.68,"profit":true},{"date":"2022-12-31","value":44.1,"profit":true},{"date":"2023-12-31","value":88.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(17.00K)(30.00K)(198.00K)(399.00K)(449.00K)[{"date":"2020-12-31","value":-1700000,"profit":false},{"date":"2021-12-31","value":-3000000,"profit":false},{"date":"2022-12-31","value":-19800000,"profit":false},{"date":"2023-12-31","value":-39900000,"profit":false},{"date":"2024-12-31","value":-44900000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses5.74M9.80M12.82M31.67M40.00M[{"date":"2020-12-31","value":14.36,"profit":true},{"date":"2021-12-31","value":24.49,"profit":true},{"date":"2022-12-31","value":32.06,"profit":true},{"date":"2023-12-31","value":79.18,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(5.74M)(9.80M)(12.82M)(31.67M)(40.00M)[{"date":"2020-12-31","value":-574300000,"profit":false},{"date":"2021-12-31","value":-979700000,"profit":false},{"date":"2022-12-31","value":-1282100000,"profit":false},{"date":"2023-12-31","value":-3166800000,"profit":false},{"date":"2024-12-31","value":-3999600000,"profit":false}]
Total Non-Operating Income/Expense(18.00K)136.00K180.00K94.00K7.58M[{"date":"2020-12-31","value":-0.24,"profit":false},{"date":"2021-12-31","value":1.8,"profit":true},{"date":"2022-12-31","value":2.38,"profit":true},{"date":"2023-12-31","value":1.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(5.75M)(9.67M)(12.65M)(31.62M)(36.14M)[{"date":"2020-12-31","value":-575200000,"profit":false},{"date":"2021-12-31","value":-966600000,"profit":false},{"date":"2022-12-31","value":-1264800000,"profit":false},{"date":"2023-12-31","value":-3162300000,"profit":false},{"date":"2024-12-31","value":-3613800000,"profit":false}]
Income Taxes1.00K126.00K(173.00K)9.00K6.00K[{"date":"2020-12-31","value":0.79,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-137.3,"profit":false},{"date":"2023-12-31","value":7.14,"profit":true},{"date":"2024-12-31","value":4.76,"profit":true}]
Income After Taxes(5.75M)(9.79M)(12.47M)(31.63M)(36.14M)[{"date":"2020-12-31","value":-575300000,"profit":false},{"date":"2021-12-31","value":-979200000,"profit":false},{"date":"2022-12-31","value":-1247500000,"profit":false},{"date":"2023-12-31","value":-3163200000,"profit":false},{"date":"2024-12-31","value":-3614400000,"profit":false}]
Income From Continuous Operations(5.75M)(9.67M)(12.65M)(31.63M)(36.14M)[{"date":"2020-12-31","value":-575300000,"profit":false},{"date":"2021-12-31","value":-966600000,"profit":false},{"date":"2022-12-31","value":-1264800000,"profit":false},{"date":"2023-12-31","value":-3163200000,"profit":false},{"date":"2024-12-31","value":-3614400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(5.75M)(9.67M)(12.65M)(31.63M)(36.14M)[{"date":"2020-12-31","value":-575300000,"profit":false},{"date":"2021-12-31","value":-966600000,"profit":false},{"date":"2022-12-31","value":-1264800000,"profit":false},{"date":"2023-12-31","value":-3163200000,"profit":false},{"date":"2024-12-31","value":-3614400000,"profit":false}]
EPS (Diluted)-(0.20)(0.96)(1.24)(1.18)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-20,"profit":false},{"date":"2022-12-31","value":-96,"profit":false},{"date":"2023-12-31","value":-124,"profit":false},{"date":"2024-12-31","value":-118,"profit":false}]

Belite Bio Inc ADR Ratios

Belite Bio Inc ADR Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

BLTE
Current Ratio 34.37

Belite Bio Inc ADR Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BLTE
ROA (LTM) -21.22%
ROE (LTM) -32.30%

Belite Bio Inc ADR Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BLTE
Debt Ratio Lower is generally better. Negative is bad. 0.03
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.97

Belite Bio Inc ADR Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BLTE
Trailing PE NM
Forward PE 222.22
P/S (TTM) 0.00
P/B 24.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Belite Bio Inc ADR share price today?

Belite Bio Inc ADR (BLTE) share price today is $173.441

Can Indians buy Belite Bio Inc ADR shares?

Yes, Indians can buy shares of Belite Bio Inc ADR (BLTE) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BLTE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Belite Bio Inc ADR be purchased?

Yes, you can purchase fractional shares of Belite Bio Inc ADR (BLTE) via the Vested app. You can start investing in Belite Bio Inc ADR (BLTE) with a minimum investment of $1.

How to invest in Belite Bio Inc ADR shares from India?

You can invest in shares of Belite Bio Inc ADR (BLTE) via Vested in three simple steps:

  • Click on Sign Up or Invest in BLTE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Belite Bio Inc ADR shares
What is Belite Bio Inc ADR 52-week high and low stock price?

The 52-week high price of Belite Bio Inc ADR (BLTE) is $200. The 52-week low price of Belite Bio Inc ADR (BLTE) is $49.

What is Belite Bio Inc ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Belite Bio Inc ADR (BLTE) is

What is Belite Bio Inc ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Belite Bio Inc ADR (BLTE) is 24.00

What is Belite Bio Inc ADR dividend yield?

The dividend yield of Belite Bio Inc ADR (BLTE) is 0.00%

What is the Market Cap of Belite Bio Inc ADR?

The market capitalization of Belite Bio Inc ADR (BLTE) is $6.60B

What is Belite Bio Inc ADR's stock symbol?

The stock symbol (or ticker) of Belite Bio Inc ADR is BLTE

How Can Investors Use Belite Bio Inc ADR Share Price Data for Long-Term Investment Decisions?

Consider the share price of Belite Bio Inc ADR as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Belite Bio Inc ADR has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Belite Bio Inc ADR shares for Indian investors?

When investing in Belite Bio Inc ADR shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Belite Bio Inc ADR stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Belite Bio Inc ADR share price with other stocks in the same sector?

Rather than merely checking the share price of Belite Bio Inc ADR and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Belite Bio Inc ADR stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top